Key result
The fractional-dose inactivated poliovirus vaccine campaign achieved an estimated coverage of 82% based on finger-marking among children aged 4 to 23 months.
Cross-Sectional (n=2,100)
Yes
Fractional-dose IPV can achieve high coverage in response to VDPV2 isolation, though operational challenges must be managed.
No takes yet. Share an insight, caveat, or question.
Fractional-dose IPV may enable effective outbreak responses; leaves open confirmation of sustained immunity and broader applicability.
Pervaiz et al. (2017) conducted a cross-sectional in Poliovirus vaccination (n=2,100). Fractional-dose inactivated poliovirus vaccine (fIPV) was evaluated on Estimated vaccination coverage based on finger-marking (95% CI 78%-85%). The fractional-dose inactivated poliovirus vaccine campaign achieved an estimated coverage of 82% based on finger-marking among children aged 4 to 23 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: